- Current report filing (8-K)
April 24 2012 - 1:49PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
|
April 18, 2012
|
ENCISION INC.
|
(Exact name of registrant as specified in its charter)
|
Colorado
|
001-11789
|
84-1162056
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
6797 Winchester Circle, Boulder, Colorado
|
80301
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code
|
(303) 444-2600
|
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction
A.2. below):
|
¨
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02.
|
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
|
On April 18, 2012, Encision Inc. appointed
Patrick W. Pace, M.D. to the Company’s board of directors, effective immediately. Dr. Pace, age 40, is the owner of PICO
LLC, a healthcare consulting firm. Dr. Pace’s background includes over 10 years of financial experience in the healthcare
sector. From 2009 to 2011, he was a Managing Director at Citadel Securities, where he was part of the inaugural team that helped
launch the firm's investment banking and credit sales and trading efforts. In this capacity, he provided credit analysis for the
healthcare sector. From 2006 to 2009, he was a Vice President at AIG Investments, where he focused on healthcare investments in
the high yield bond market. From 2001 to 2006, Dr. Pace held various positions at UBS, including serving as Senior Analyst in equity
research covering the medical device sector from 2003 to 2006. Dr. Pace also serves on the board of directors for Nanospectra Biosciences,
Inc., a privately-held medical device company. Dr. Pace holds an M.D. from the University of Texas Medical School – Houston
and a B.A. (Honors in Psychology) from Vanderbilt University.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
ENCISION INC.
|
|
|
|
|
|
Date:
April 24, 2012
|
|
/s/
Marcia K. McHaffie
|
|
|
|
Marcia K. McHaffie
|
|
|
|
Controller
|
|
|
|
Principal Accounting Officer
|
|
Encision (PK) (USOTC:ECIA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Encision (PK) (USOTC:ECIA)
Historical Stock Chart
From Jul 2023 to Jul 2024